Unexpectedly, GSH level and GPX4 activity were slightly but significantly elevated in FLRT2‐overexpressed bladder cancer cells, suggesting a compensatory protection of GSH/GPX4 (Figure 4H,I). This evidence concerns the gene GPX4 and urinary bladder carcinoma.